Sakisaka, H.; Takedatsu, H.; Mitsuyama, K.; Mochizuki, S.; Sakurai, K.; Sakisaka, S.; Hirai, F.
Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation. Int. J. Mol. Sci. 2020, 21, 683.
https://doi.org/10.3390/ijms21020683
AMA Style
Sakisaka H, Takedatsu H, Mitsuyama K, Mochizuki S, Sakurai K, Sakisaka S, Hirai F.
Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation. International Journal of Molecular Sciences. 2020; 21(2):683.
https://doi.org/10.3390/ijms21020683
Chicago/Turabian Style
Sakisaka, Hideto, Hidetoshi Takedatsu, Keiichi Mitsuyama, Shinichi Mochizuki, Kazuo Sakurai, Shotaro Sakisaka, and Fumihito Hirai.
2020. "Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation" International Journal of Molecular Sciences 21, no. 2: 683.
https://doi.org/10.3390/ijms21020683
APA Style
Sakisaka, H., Takedatsu, H., Mitsuyama, K., Mochizuki, S., Sakurai, K., Sakisaka, S., & Hirai, F.
(2020). Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation. International Journal of Molecular Sciences, 21(2), 683.
https://doi.org/10.3390/ijms21020683
